Search companies or stocks...
NEONeoGenomics, Inc.
At close · 02 Sept 2026, 08:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services…
Current stock price of NeoGenomics, Inc. (NEO) stock is $17.400. The stock price is -0.29% lower in the session. The intraday range can be seen from this page. Volume of NeoGenomics, Inc. (NEO) stock is 1.79M.
Last updated at 02 Sept 2026, 08:00 pm.
The stock price of NeoGenomics, Inc. (NEO) can change with earnings, company news, and overall market sentiment. NeoGenomics, Inc. operates in the Healthcare / Medical - Diagnostics & Research market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether NeoGenomics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for NEO on this page is 133.85. EPS on this page is 0.13. Compare those figures with peers and growth expectations before deciding if the current NeoGenomics, Inc. price is justified.
Historical performance for NeoGenomics, Inc. (NEO) is shown on the price chart on this page. Review multi-period moves alongside volume to see how NEO reacted to past earnings and market events.
Buying NeoGenomics, Inc. (NEO) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
